AbbVie to Unveil Promising Phase 3 Etentamig Data at 2026 International Myeloma Society Annual Meeting #USA #AbbVie #North_Chicago #Myeloma #Etentamig
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAbbVie's Phase 3 CERVINO Trial Results Show Promising Efficacy of Etentamig in Multiple Myeloma Patients #United_States #Multiple_Myeloma #AbbVie #North_Chicago #Etentamig